nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0545	0.403	CbGbCtD
Oxycodone—CYP2D6—Captopril—systemic scleroderma	0.0424	0.314	CbGbCtD
Oxycodone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0212	0.157	CbGbCtD
Oxycodone—CYP3A4—Prednisone—systemic scleroderma	0.017	0.126	CbGbCtD
Oxycodone—Constipation—Mycophenolic acid—systemic scleroderma	0.000463	0.000536	CcSEcCtD
Oxycodone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000463	0.000535	CcSEcCtD
Oxycodone—Weight decreased—Prednisone—systemic scleroderma	0.000461	0.000533	CcSEcCtD
Oxycodone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00046	0.000532	CcSEcCtD
Oxycodone—Hyperglycaemia—Prednisone—systemic scleroderma	0.00046	0.000531	CcSEcCtD
Oxycodone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000457	0.000528	CcSEcCtD
Oxycodone—Hypotension—Lisinopril—systemic scleroderma	0.000456	0.000527	CcSEcCtD
Oxycodone—Dizziness—Captopril—systemic scleroderma	0.000456	0.000527	CcSEcCtD
Oxycodone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000525	CcSEcCtD
Oxycodone—Urticaria—Leflunomide—systemic scleroderma	0.000451	0.000522	CcSEcCtD
Oxycodone—Abdominal pain—Leflunomide—systemic scleroderma	0.000449	0.000519	CcSEcCtD
Oxycodone—Body temperature increased—Leflunomide—systemic scleroderma	0.000449	0.000519	CcSEcCtD
Oxycodone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000446	0.000516	CcSEcCtD
Oxycodone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000516	CcSEcCtD
Oxycodone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000516	CcSEcCtD
Oxycodone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000516	CcSEcCtD
Oxycodone—Breast disorder—Methotrexate—systemic scleroderma	0.000445	0.000515	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000444	0.000514	CcSEcCtD
Oxycodone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000444	0.000514	CcSEcCtD
Oxycodone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000443	0.000512	CcSEcCtD
Oxycodone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000443	0.000512	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000443	0.000512	CcSEcCtD
Oxycodone—Insomnia—Lisinopril—systemic scleroderma	0.000441	0.00051	CcSEcCtD
Oxycodone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000441	0.000509	CcSEcCtD
Oxycodone—Paraesthesia—Lisinopril—systemic scleroderma	0.000438	0.000507	CcSEcCtD
Oxycodone—Vomiting—Captopril—systemic scleroderma	0.000438	0.000506	CcSEcCtD
Oxycodone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000436	0.000504	CcSEcCtD
Oxycodone—Dyspnoea—Lisinopril—systemic scleroderma	0.000435	0.000503	CcSEcCtD
Oxycodone—Rash—Captopril—systemic scleroderma	0.000434	0.000502	CcSEcCtD
Oxycodone—Dermatitis—Captopril—systemic scleroderma	0.000434	0.000502	CcSEcCtD
Oxycodone—Somnolence—Lisinopril—systemic scleroderma	0.000434	0.000502	CcSEcCtD
Oxycodone—Headache—Captopril—systemic scleroderma	0.000432	0.000499	CcSEcCtD
Oxycodone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000431	0.000498	CcSEcCtD
Oxycodone—Dyspepsia—Lisinopril—systemic scleroderma	0.000429	0.000497	CcSEcCtD
Oxycodone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000428	0.000495	CcSEcCtD
Oxycodone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000428	0.000495	CcSEcCtD
Oxycodone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000427	0.000494	CcSEcCtD
Oxycodone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000427	0.000494	CcSEcCtD
Oxycodone—Asthma—Methotrexate—systemic scleroderma	0.000426	0.000492	CcSEcCtD
Oxycodone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000425	0.000491	CcSEcCtD
Oxycodone—Decreased appetite—Lisinopril—systemic scleroderma	0.000424	0.00049	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000421	0.000487	CcSEcCtD
Oxycodone—Fatigue—Lisinopril—systemic scleroderma	0.000421	0.000486	CcSEcCtD
Oxycodone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000421	0.000486	CcSEcCtD
Oxycodone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000419	0.000485	CcSEcCtD
Oxycodone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000418	0.000484	CcSEcCtD
Oxycodone—Constipation—Lisinopril—systemic scleroderma	0.000417	0.000482	CcSEcCtD
Oxycodone—Pain—Lisinopril—systemic scleroderma	0.000417	0.000482	CcSEcCtD
Oxycodone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000417	0.000482	CcSEcCtD
Oxycodone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00048	CcSEcCtD
Oxycodone—Bradycardia—Prednisone—systemic scleroderma	0.000415	0.00048	CcSEcCtD
Oxycodone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000413	0.000478	CcSEcCtD
Oxycodone—Diarrhoea—Azathioprine—systemic scleroderma	0.000411	0.000476	CcSEcCtD
Oxycodone—Haemoglobin—Prednisone—systemic scleroderma	0.00041	0.000474	CcSEcCtD
Oxycodone—Nausea—Captopril—systemic scleroderma	0.000409	0.000473	CcSEcCtD
Oxycodone—Haemorrhage—Prednisone—systemic scleroderma	0.000408	0.000472	CcSEcCtD
Oxycodone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000407	0.000471	CcSEcCtD
Oxycodone—Asthenia—Leflunomide—systemic scleroderma	0.000407	0.000471	CcSEcCtD
Oxycodone—Hallucination—Prednisone—systemic scleroderma	0.000406	0.000469	CcSEcCtD
Oxycodone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000402	0.000465	CcSEcCtD
Oxycodone—Pruritus—Leflunomide—systemic scleroderma	0.000402	0.000464	CcSEcCtD
Oxycodone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000401	0.000463	CcSEcCtD
Oxycodone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000399	0.000462	CcSEcCtD
Oxycodone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000399	0.000461	CcSEcCtD
Oxycodone—Dysuria—Methotrexate—systemic scleroderma	0.000398	0.00046	CcSEcCtD
Oxycodone—Dizziness—Azathioprine—systemic scleroderma	0.000398	0.00046	CcSEcCtD
Oxycodone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000392	0.000453	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000389	0.00045	CcSEcCtD
Oxycodone—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000389	0.000449	CcSEcCtD
Oxycodone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000389	0.000449	CcSEcCtD
Oxycodone—Diarrhoea—Leflunomide—systemic scleroderma	0.000388	0.000449	CcSEcCtD
Oxycodone—Urticaria—Lisinopril—systemic scleroderma	0.000388	0.000448	CcSEcCtD
Oxycodone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000387	0.000447	CcSEcCtD
Oxycodone—Body temperature increased—Lisinopril—systemic scleroderma	0.000386	0.000446	CcSEcCtD
Oxycodone—Abdominal pain—Lisinopril—systemic scleroderma	0.000386	0.000446	CcSEcCtD
Oxycodone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000384	0.000444	CcSEcCtD
Oxycodone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000383	0.000443	CcSEcCtD
Oxycodone—Vomiting—Azathioprine—systemic scleroderma	0.000382	0.000442	CcSEcCtD
Oxycodone—Pneumonia—Methotrexate—systemic scleroderma	0.000382	0.000442	CcSEcCtD
Oxycodone—Eye disorder—Prednisone—systemic scleroderma	0.000381	0.000441	CcSEcCtD
Oxycodone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000381	0.000441	CcSEcCtD
Oxycodone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00038	0.000439	CcSEcCtD
Oxycodone—Infestation—Methotrexate—systemic scleroderma	0.00038	0.000439	CcSEcCtD
Oxycodone—Infestation NOS—Methotrexate—systemic scleroderma	0.00038	0.000439	CcSEcCtD
Oxycodone—Drowsiness—Methotrexate—systemic scleroderma	0.00038	0.000439	CcSEcCtD
Oxycodone—Rash—Azathioprine—systemic scleroderma	0.000379	0.000438	CcSEcCtD
Oxycodone—Dermatitis—Azathioprine—systemic scleroderma	0.000379	0.000438	CcSEcCtD
Oxycodone—Flushing—Prednisone—systemic scleroderma	0.000378	0.000438	CcSEcCtD
Oxycodone—Headache—Azathioprine—systemic scleroderma	0.000377	0.000436	CcSEcCtD
Oxycodone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000376	0.000435	CcSEcCtD
Oxycodone—Dizziness—Leflunomide—systemic scleroderma	0.000375	0.000434	CcSEcCtD
Oxycodone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000372	0.00043	CcSEcCtD
Oxycodone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000371	0.000429	CcSEcCtD
Oxycodone—Stomatitis—Methotrexate—systemic scleroderma	0.00037	0.000428	CcSEcCtD
Oxycodone—Angiopathy—Prednisone—systemic scleroderma	0.00037	0.000428	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000369	0.000427	CcSEcCtD
Oxycodone—Immune system disorder—Prednisone—systemic scleroderma	0.000368	0.000426	CcSEcCtD
Oxycodone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000366	0.000423	CcSEcCtD
Oxycodone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000366	0.000423	CcSEcCtD
Oxycodone—Sweating—Methotrexate—systemic scleroderma	0.000364	0.000421	CcSEcCtD
Oxycodone—Haematuria—Methotrexate—systemic scleroderma	0.000362	0.000419	CcSEcCtD
Oxycodone—Vomiting—Leflunomide—systemic scleroderma	0.000361	0.000417	CcSEcCtD
Oxycodone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000359	0.000416	CcSEcCtD
Oxycodone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000359	0.000415	CcSEcCtD
Oxycodone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000358	0.000414	CcSEcCtD
Oxycodone—Epistaxis—Methotrexate—systemic scleroderma	0.000358	0.000414	CcSEcCtD
Oxycodone—Rash—Leflunomide—systemic scleroderma	0.000358	0.000414	CcSEcCtD
Oxycodone—Dermatitis—Leflunomide—systemic scleroderma	0.000358	0.000414	CcSEcCtD
Oxycodone—Mental disorder—Prednisone—systemic scleroderma	0.000357	0.000413	CcSEcCtD
Oxycodone—Nausea—Azathioprine—systemic scleroderma	0.000357	0.000413	CcSEcCtD
Oxycodone—Headache—Leflunomide—systemic scleroderma	0.000356	0.000411	CcSEcCtD
Oxycodone—Malnutrition—Prednisone—systemic scleroderma	0.000355	0.000411	CcSEcCtD
Oxycodone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000352	0.000407	CcSEcCtD
Oxycodone—Asthenia—Lisinopril—systemic scleroderma	0.00035	0.000405	CcSEcCtD
Oxycodone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00035	0.000404	CcSEcCtD
Oxycodone—Pruritus—Lisinopril—systemic scleroderma	0.000345	0.000399	CcSEcCtD
Oxycodone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000344	0.000398	CcSEcCtD
Oxycodone—Haemoglobin—Methotrexate—systemic scleroderma	0.000343	0.000396	CcSEcCtD
Oxycodone—Rash—Mycophenolic acid—systemic scleroderma	0.000342	0.000395	CcSEcCtD
Oxycodone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000341	0.000395	CcSEcCtD
Oxycodone—Haemorrhage—Methotrexate—systemic scleroderma	0.000341	0.000394	CcSEcCtD
Oxycodone—Hepatitis—Methotrexate—systemic scleroderma	0.000341	0.000394	CcSEcCtD
Oxycodone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00034	0.000393	CcSEcCtD
Oxycodone—Headache—Mycophenolic acid—systemic scleroderma	0.000339	0.000392	CcSEcCtD
Oxycodone—Pharyngitis—Methotrexate—systemic scleroderma	0.000338	0.000391	CcSEcCtD
Oxycodone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000391	CcSEcCtD
Oxycodone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000391	CcSEcCtD
Oxycodone—Nausea—Leflunomide—systemic scleroderma	0.000337	0.00039	CcSEcCtD
Oxycodone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000337	0.000389	CcSEcCtD
Oxycodone—Urethral disorder—Methotrexate—systemic scleroderma	0.000334	0.000386	CcSEcCtD
Oxycodone—Diarrhoea—Lisinopril—systemic scleroderma	0.000334	0.000386	CcSEcCtD
Oxycodone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000329	0.000381	CcSEcCtD
Oxycodone—Visual impairment—Methotrexate—systemic scleroderma	0.000328	0.00038	CcSEcCtD
Oxycodone—Anaemia—Prednisone—systemic scleroderma	0.000328	0.000379	CcSEcCtD
Oxycodone—Agitation—Prednisone—systemic scleroderma	0.000326	0.000377	CcSEcCtD
Oxycodone—Angioedema—Prednisone—systemic scleroderma	0.000324	0.000375	CcSEcCtD
Oxycodone—Dizziness—Lisinopril—systemic scleroderma	0.000323	0.000373	CcSEcCtD
Oxycodone—Nausea—Mycophenolic acid—systemic scleroderma	0.000322	0.000372	CcSEcCtD
Oxycodone—Malaise—Prednisone—systemic scleroderma	0.00032	0.00037	CcSEcCtD
Oxycodone—Vertigo—Prednisone—systemic scleroderma	0.000319	0.000369	CcSEcCtD
Oxycodone—Eye disorder—Methotrexate—systemic scleroderma	0.000319	0.000368	CcSEcCtD
Oxycodone—Syncope—Prednisone—systemic scleroderma	0.000318	0.000368	CcSEcCtD
Oxycodone—Tinnitus—Methotrexate—systemic scleroderma	0.000318	0.000367	CcSEcCtD
Oxycodone—Cardiac disorder—Methotrexate—systemic scleroderma	0.000316	0.000366	CcSEcCtD
Oxycodone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000364	CcSEcCtD
Oxycodone—Loss of consciousness—Prednisone—systemic scleroderma	0.000312	0.000361	CcSEcCtD
Oxycodone—Vomiting—Lisinopril—systemic scleroderma	0.00031	0.000359	CcSEcCtD
Oxycodone—Angiopathy—Methotrexate—systemic scleroderma	0.000309	0.000358	CcSEcCtD
Oxycodone—Immune system disorder—Methotrexate—systemic scleroderma	0.000308	0.000356	CcSEcCtD
Oxycodone—Rash—Lisinopril—systemic scleroderma	0.000308	0.000356	CcSEcCtD
Oxycodone—Convulsion—Prednisone—systemic scleroderma	0.000308	0.000356	CcSEcCtD
Oxycodone—Dermatitis—Lisinopril—systemic scleroderma	0.000307	0.000355	CcSEcCtD
Oxycodone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000307	0.000355	CcSEcCtD
Oxycodone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000355	CcSEcCtD
Oxycodone—Chills—Methotrexate—systemic scleroderma	0.000306	0.000354	CcSEcCtD
Oxycodone—Headache—Lisinopril—systemic scleroderma	0.000306	0.000353	CcSEcCtD
Oxycodone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000302	0.00035	CcSEcCtD
Oxycodone—Arthralgia—Prednisone—systemic scleroderma	0.000302	0.000349	CcSEcCtD
Oxycodone—Myalgia—Prednisone—systemic scleroderma	0.000302	0.000349	CcSEcCtD
Oxycodone—Anxiety—Prednisone—systemic scleroderma	0.000301	0.000348	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.0003	0.000347	CcSEcCtD
Oxycodone—Discomfort—Prednisone—systemic scleroderma	0.000299	0.000345	CcSEcCtD
Oxycodone—Mental disorder—Methotrexate—systemic scleroderma	0.000299	0.000345	CcSEcCtD
Oxycodone—Malnutrition—Methotrexate—systemic scleroderma	0.000297	0.000343	CcSEcCtD
Oxycodone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000338	CcSEcCtD
Oxycodone—Dysgeusia—Methotrexate—systemic scleroderma	0.000291	0.000336	CcSEcCtD
Oxycodone—Nausea—Lisinopril—systemic scleroderma	0.00029	0.000335	CcSEcCtD
Oxycodone—Oedema—Prednisone—systemic scleroderma	0.00029	0.000335	CcSEcCtD
Oxycodone—Anaphylactic shock—Prednisone—systemic scleroderma	0.00029	0.000335	CcSEcCtD
Oxycodone—Infection—Prednisone—systemic scleroderma	0.000288	0.000333	CcSEcCtD
Oxycodone—Back pain—Methotrexate—systemic scleroderma	0.000287	0.000332	CcSEcCtD
Oxycodone—Shock—Prednisone—systemic scleroderma	0.000285	0.00033	CcSEcCtD
Oxycodone—Nervous system disorder—Prednisone—systemic scleroderma	0.000284	0.000329	CcSEcCtD
Oxycodone—Tachycardia—Prednisone—systemic scleroderma	0.000283	0.000327	CcSEcCtD
Oxycodone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000283	0.000327	CcSEcCtD
Oxycodone—Skin disorder—Prednisone—systemic scleroderma	0.000281	0.000325	CcSEcCtD
Oxycodone—Hyperhidrosis—Prednisone—systemic scleroderma	0.00028	0.000324	CcSEcCtD
Oxycodone—Anorexia—Prednisone—systemic scleroderma	0.000276	0.000319	CcSEcCtD
Oxycodone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000275	0.000318	CcSEcCtD
Oxycodone—Anaemia—Methotrexate—systemic scleroderma	0.000274	0.000317	CcSEcCtD
Oxycodone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000314	CcSEcCtD
Oxycodone—Rash—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000312	CcSEcCtD
Oxycodone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000311	CcSEcCtD
Oxycodone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000268	0.00031	CcSEcCtD
Oxycodone—Malaise—Methotrexate—systemic scleroderma	0.000268	0.000309	CcSEcCtD
Oxycodone—Vertigo—Methotrexate—systemic scleroderma	0.000267	0.000308	CcSEcCtD
Oxycodone—Leukopenia—Methotrexate—systemic scleroderma	0.000266	0.000307	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000264	0.000305	CcSEcCtD
Oxycodone—Insomnia—Prednisone—systemic scleroderma	0.000262	0.000303	CcSEcCtD
Oxycodone—Paraesthesia—Prednisone—systemic scleroderma	0.00026	0.000301	CcSEcCtD
Oxycodone—Cough—Methotrexate—systemic scleroderma	0.000259	0.000299	CcSEcCtD
Oxycodone—Convulsion—Methotrexate—systemic scleroderma	0.000257	0.000297	CcSEcCtD
Oxycodone—Dyspepsia—Prednisone—systemic scleroderma	0.000255	0.000295	CcSEcCtD
Oxycodone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000294	CcSEcCtD
Oxycodone—Arthralgia—Methotrexate—systemic scleroderma	0.000253	0.000292	CcSEcCtD
Oxycodone—Chest pain—Methotrexate—systemic scleroderma	0.000253	0.000292	CcSEcCtD
Oxycodone—Myalgia—Methotrexate—systemic scleroderma	0.000253	0.000292	CcSEcCtD
Oxycodone—Decreased appetite—Prednisone—systemic scleroderma	0.000252	0.000291	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000251	0.00029	CcSEcCtD
Oxycodone—Fatigue—Prednisone—systemic scleroderma	0.00025	0.000289	CcSEcCtD
Oxycodone—Discomfort—Methotrexate—systemic scleroderma	0.00025	0.000289	CcSEcCtD
Oxycodone—Constipation—Prednisone—systemic scleroderma	0.000248	0.000287	CcSEcCtD
Oxycodone—Confusional state—Methotrexate—systemic scleroderma	0.000244	0.000282	CcSEcCtD
Oxycodone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000242	0.00028	CcSEcCtD
Oxycodone—Infection—Methotrexate—systemic scleroderma	0.000241	0.000278	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisone—systemic scleroderma	0.000239	0.000276	CcSEcCtD
Oxycodone—Nervous system disorder—Methotrexate—systemic scleroderma	0.000237	0.000275	CcSEcCtD
Oxycodone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000237	0.000274	CcSEcCtD
Oxycodone—Skin disorder—Methotrexate—systemic scleroderma	0.000235	0.000272	CcSEcCtD
Oxycodone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000234	0.000271	CcSEcCtD
Oxycodone—Anorexia—Methotrexate—systemic scleroderma	0.000231	0.000267	CcSEcCtD
Oxycodone—Urticaria—Prednisone—systemic scleroderma	0.00023	0.000266	CcSEcCtD
Oxycodone—Abdominal pain—Prednisone—systemic scleroderma	0.000229	0.000265	CcSEcCtD
Oxycodone—Body temperature increased—Prednisone—systemic scleroderma	0.000229	0.000265	CcSEcCtD
Oxycodone—Hypotension—Methotrexate—systemic scleroderma	0.000226	0.000262	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000221	0.000255	CcSEcCtD
Oxycodone—Insomnia—Methotrexate—systemic scleroderma	0.000219	0.000253	CcSEcCtD
Oxycodone—Paraesthesia—Methotrexate—systemic scleroderma	0.000217	0.000251	CcSEcCtD
Oxycodone—Dyspnoea—Methotrexate—systemic scleroderma	0.000216	0.00025	CcSEcCtD
Oxycodone—Somnolence—Methotrexate—systemic scleroderma	0.000215	0.000249	CcSEcCtD
Oxycodone—Hypersensitivity—Prednisone—systemic scleroderma	0.000213	0.000247	CcSEcCtD
Oxycodone—Dyspepsia—Methotrexate—systemic scleroderma	0.000213	0.000246	CcSEcCtD
Oxycodone—Decreased appetite—Methotrexate—systemic scleroderma	0.00021	0.000243	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000209	0.000242	CcSEcCtD
Oxycodone—Fatigue—Methotrexate—systemic scleroderma	0.000209	0.000241	CcSEcCtD
Oxycodone—Asthenia—Prednisone—systemic scleroderma	0.000208	0.00024	CcSEcCtD
Oxycodone—Pain—Methotrexate—systemic scleroderma	0.000207	0.000239	CcSEcCtD
Oxycodone—Pruritus—Prednisone—systemic scleroderma	0.000205	0.000237	CcSEcCtD
Oxycodone—Feeling abnormal—Methotrexate—systemic scleroderma	0.0002	0.000231	CcSEcCtD
Oxycodone—Diarrhoea—Prednisone—systemic scleroderma	0.000198	0.000229	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000198	0.000229	CcSEcCtD
Oxycodone—Urticaria—Methotrexate—systemic scleroderma	0.000192	0.000222	CcSEcCtD
Oxycodone—Dizziness—Prednisone—systemic scleroderma	0.000192	0.000222	CcSEcCtD
Oxycodone—Body temperature increased—Methotrexate—systemic scleroderma	0.000191	0.000221	CcSEcCtD
Oxycodone—Abdominal pain—Methotrexate—systemic scleroderma	0.000191	0.000221	CcSEcCtD
Oxycodone—Vomiting—Prednisone—systemic scleroderma	0.000184	0.000213	CcSEcCtD
Oxycodone—Rash—Prednisone—systemic scleroderma	0.000183	0.000211	CcSEcCtD
Oxycodone—Dermatitis—Prednisone—systemic scleroderma	0.000183	0.000211	CcSEcCtD
Oxycodone—Headache—Prednisone—systemic scleroderma	0.000182	0.00021	CcSEcCtD
Oxycodone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000178	0.000206	CcSEcCtD
Oxycodone—Asthenia—Methotrexate—systemic scleroderma	0.000174	0.000201	CcSEcCtD
Oxycodone—Nausea—Prednisone—systemic scleroderma	0.000172	0.000199	CcSEcCtD
Oxycodone—Pruritus—Methotrexate—systemic scleroderma	0.000171	0.000198	CcSEcCtD
Oxycodone—Diarrhoea—Methotrexate—systemic scleroderma	0.000166	0.000192	CcSEcCtD
Oxycodone—Dizziness—Methotrexate—systemic scleroderma	0.00016	0.000185	CcSEcCtD
Oxycodone—Vomiting—Methotrexate—systemic scleroderma	0.000154	0.000178	CcSEcCtD
Oxycodone—Rash—Methotrexate—systemic scleroderma	0.000153	0.000177	CcSEcCtD
Oxycodone—Dermatitis—Methotrexate—systemic scleroderma	0.000153	0.000176	CcSEcCtD
Oxycodone—Headache—Methotrexate—systemic scleroderma	0.000152	0.000175	CcSEcCtD
Oxycodone—Nausea—Methotrexate—systemic scleroderma	0.000144	0.000166	CcSEcCtD
